(Q43812437)

27 November 2017

title

Pathologic downstaging of T3-4Nx rectal cancer after chemoradiation: 5-fluorouracil vs. Tegafur (English)

1 reference

27 November 2017

0 references

1 reference

Calvo FA

1

1 reference

27 November 2017

Gómez-Espí M

2

1 reference

27 November 2017

Díaz-González JA

3

1 reference

27 November 2017

Cantalapiedra R

4

1 reference

27 November 2017

Marcos P

5

1 reference

27 November 2017

Alvarado A

6

1 reference

27 November 2017

García Alfonso P

7

1 reference

27 November 2017

Herranz R

8

1 reference

27 November 2017

Alvarez E

9

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

International Journal of Radiation Oncology Biology Physics

27 November 2017

published in

1 reference

27 November 2017

volume

51

1 reference

27 November 2017

issue

5

1 reference

27 November 2017

page(s)

1264-1270

1 reference

Preoperative radiotherapy for resectable rectal cancer: A meta-analysis

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901728-X

7 January 2021

Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901728-X

7 January 2021

A comparison of nonoperative vs. preoperative radiotherapy in rectal carcinoma. A 10-year randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901728-X

7 January 2021

Final results of a randomized trial on the treatment of rectal cancer with preoperative radiotherapy alone or in combination with 5-fluorouracil, followed by radical surgery. Trial of the European Organization on Research and Treatment of Cancer Gas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901728-X

7 January 2021

Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901728-X

7 January 2021

Improved survival with preoperative radiotherapy in resectable rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901728-X

7 January 2021

Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901728-X

7 January 2021

A selective approach to adjunctive therapy for cancer of the rectum

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901728-X

7 January 2021

Preoperative infusional chemoradiation therapy for Stage T3 rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901728-X

7 January 2021

Preoperative radiochemotherapy in rectal cancer: long-term results of a phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901728-X

7 January 2021

A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: a progress report of National Surgical Breast and Bowel Project Protocol R-03

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901728-X

7 January 2021

Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901728-X

7 January 2021

Irradiation Plus 5-Fluorouracil: Cellular Mechanisms of Action and Treatment Schedules

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901728-X

7 January 2021

Oral tegafur in the treatment of gastrointestinal tract cancers: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901728-X

7 January 2021

Randomized clinical trial of adjuvant mitomycin plus tegafur in patients with resected stage III gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901728-X

7 January 2021

Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901728-X

7 January 2021

LENT SOMA scales for all anatomic sites

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901728-X

7 January 2021

Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901728-X

7 January 2021

Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901728-X

7 January 2021

A review of the United States clinical experience of the fluoropyrimidine, ftorafur (NSC-148958).

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901728-X

7 January 2021

Phase I-II studies of oral tegafur (ftorafur)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901728-X

7 January 2021

A comparative study of oral tegafur and intravenous 5-fluorouracil in patients with metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901728-X

7 January 2021

Phase I study of preoperative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901728-X

7 January 2021

Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901728-X

7 January 2021

Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901728-X

7 January 2021

Patterns of residual disease after preoperative chemoradiation in ultrasound T3 rectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901728-X

7 January 2021

Sphincter preservation therapy for distal rectal carcinoma: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901728-X

7 January 2021

Low rectal cancer: impact of radiation and chemotherapy on surgical treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901728-X

7 January 2021

10.1016/S0360-3016(01)01728-X

Identifiers

DOI

1 reference

27 November 2017

1 reference